PTO Form 1581 (Rev 4/2000) |
OMB Control #0651-0009 (Exp. 06/30/2005) |
Extension Statement of Use Filing
The table below presents the data as entered.
Input Field
|
Entered
|
SERIAL NUMBER |
76560883 |
LAW OFFICE ASSIGNED |
LAW OFFICE 105 |
MARK SECTION |
MARK |
RANEXA (stylized and/or with design) |
DESIGN MARK FILE NAME(S) |
http://tess2.gov.uspto.report/we baka/images/76560883.gif |
OWNER SECTION (no change) |
GOODS AND/OR SERVICES SECTION |
INTERNATIONAL CLASS |
005 |
KEEP EXISTING GOODS AND/OR SERVICES |
YES |
INTERNATIONAL CLASS |
016 |
KEEP EXISTING GOODS AND/OR SERVICES |
YES |
EXTENSION SECTION |
EXTENSION NUMBER |
1 |
ALLOWANCE MAIL DATE |
08/17/2004 |
STATEMENT OF USE |
NO |
PAYMENT SECTION |
NUMBER OF CLASSES |
2 |
SUBTOTAL AMOUNT |
300 |
TOTAL AMOUNT |
300 |
SIGNATURE SECTION |
SIGNATORY FILE |
Signature |
SIGNATORY NAME |
Tricia Borga Suvari |
SIGNATORY POSITION |
Vice President, General Counsel & Assistant Corporate Secretary |
FILING INFORMATION |
SUBMIT DATE |
Thu Dec 30 15:57:29 EST 2004 |
TEAS STAMP |
USPTO/ESU-XXX.XX.XXX.X-20
041230155729689104-765608
83-200606958fb85a5fc4238a
a6d22ae41eaf-CC-134-20041
230155613688162 |
PTO Form 1581 (Rev 4/2000) |
OMB Control #0651-0009 (Exp. 06/30/2005) |
Trademark/Service Mark Extension for Filing a Statement of Use
(15 U.S.C. Section 1051(d))
To the Commissioner for Trademarks:
MARK: RANEXA (stylized and/or with design)
SERIAL NUMBER: 76560883
The applicant, CV Therapeutics, residing at 3172 Porter Drive , Palo Alto, CA US 94304, requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this
application. The Notice of Allowance mailing date was 08/17/2004.
For International Class: 005, the applicant has a continued bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with all of
the goods and/or services listed in the Notice of Allowance, or as subsequently modified.
For International Class: 016, the applicant has a continued bona fide intention to use or use through the applicant's related company or licensee the mark in commerce on or in connection with all of
the goods and/or services listed in the Notice of Allowance, or as subsequently modified.
This is the first extension request.
A fee payment in the amount of $300 will be submitted with the form, representing payment for 2 classes.
|
APPLICANT NAME: |
CV Therapeutics |
MARK: |
RANEXA (stylized or with design) |
Declaration
The undersigned being hereby warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. Section 1001, and that such willful false statements
and the like may jeopardize the validity of this document, declares that he/she is properly authorized to execute this document on behalf of the Owner; and all statements made of his/her own
knowledge are true and that all statements made on information and belief are believed to be true.
Signatory's Name: Tricia Borga Suvari
Signatory's Position: Vice President, General Counsel & Assistant Corporate Secretary
Signatory File
Signature
RAM Sale Number: 134
RAM Accounting Date: 01/03/2005
Serial Number: 76560883
Internet Transmission Date: Thu Dec 30 15:57:29 EST 2004
TEAS Stamp: USPTO/ESU-XXX.XX.XXX.X-20041230155729689
104-76560883-200606958fb85a5fc4238aa6d22
ae41eaf-CC-134-20041230155613688162
Go Back